2Ruiz Gines JA, Lopez Ongil S, Gonzalez Rubio M, et al. Reactive oxy-gen species induce proliferation of bovine aortic endothelialcells[J]. J Cardiovasc Pharmacol, 2000, 3S (1) : 109-113.
3Jansen J, Hanks S, Thompson JM, et al. Transplantation of hematopoietic stem cells from the peripheral blood[J]. J Cell Mol Med, 2005, 9(1): 37-50.
4Cavallaro AM, Lilleby K, Majolino I, et al. Three to six year follow-upof normal donors who received recombinant human granulocyte colony-stimulating factor [J]. Bone Marrow Transplant, 2000, 25(1): 85-89.
7Lefrere F, Zohar S, Bresson JL, et al. A double-blind lowdosefinding phase Ⅱ study of granuloeyte colony-stimula-ting factor combined with chemotherapy for stem cell mobilization in patients with non-Hodgkin's lymphoma[J]. Haematologica, 2006, 91 (4), 550-553.
8KrogerN, Zeller W, Hassan HT, et al. Stem cell mobilization with G-CSF alone in breast cancer patients: higher progenitor cell yield by delivering divided doses(2 × 5 μg/kg) compared to a single dose (1 × 10/μg/kg) [J]. Bone Marrow Transplant, 1999, 23 :125-129.
2[1]Fischer.J,Frick M.Steady-state mobilization of PBPC: schedule dependent effective of G-CSF.Exp Hematol,1995,23:869
3[2]Ponisch W,Leiblein S,Edel E et al.Mobilization of peripheral blood progenitor cells(PBPC)in normal donor for allogeneic PBPC transplantation: comparison between once a day versus twice a day of G-CSF(filgrastim)administration.Blood,1999,94:137
4[3]Kroger N,Renges H,Kruger W et al.A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation,Br J Haematol,2000,111:761
5[5]Terstappen LW,Huang S,Safford M et al.Sequential generation of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells.Blood,1991,77(6):1218
6[6]Grigg AP,Roberts AW,Raunow H et al.Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers.Blood,1995,86:4437
7[7]Anderlini P,Przepiorka D,Seong C et al.Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim.Transfusion,1997,37:507
8Koc ON , Gerson SL , Phillips GL, et al. Autologous CD34 + cell transplantation for patients with advanced lymphoma: effects of overnight storage on peripheral blood progenitor cell enrichment and engraftment. Bone Marrow Transplant, 1998; 21:337 -343.
9Clark L, Clark O, Djulbegovic B, et al. Allogeneic peripheral blood stem cells vs. bone marrow transplantation for the therapy of hematological malignancies: a meta - analysis of randomized controlled trials. Blood, 2001; 98: 414.
10Rutella S, Rumi C, Testa U, et al. Inhibition of lymphocyte blastogenic response in healthy donors treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF): possible role of lactoferrin and interleukin-1 receptor antagonist. Bone Marrow Transplant, 1997; 20:355-364.
